Neuro-Kinesis Corporation grew out of the work that Magnetecs had achieved in developing an intuitive robotic-assisted magnetic guidance system for the precise maneuvering of a specialized catheter through the human body. Known as CGCI, Catheter Guidance Control, and Imaging system, the system used lensed magnetic arrays to provide precision navigation of a catheter tip to a targeted location for imaging, ablation, or other procedures, with the singular advantage of being able to provide repeat return-to-site with the push of a button. 

“At the core of any task is the fundamental and unassailable belief that a solution is possible.”
– Josh Shachar.

Through the system’s development at Magnetecs, Josh was able to prove the concept and build the platform from a prototype to a fully functioning operating suite with on-site installations in Europe and the US in order to conduct clinical trials for moving regulatory approval forward. Through this work, the CGCI system was able to procure several critical approvals as it moved forward to pre-commercialization status. This included CE Mark recognition, IEC Certification, UL licensing, and ISO-1345 compliance. 

In addition to the success in the development of the CGCI system, Josh and his team were able to begin pioneering a suite of specialty catheter tools that would work specifically with the CGCI system in assisting physicians with a variety of catheter-based procedures. Chief among this work was the development of a SMART Catheter that could not only perform the typical mechanical functions of a catheter but one that was equipped with Josh’s SMART Biosensor technology built right into the tip. This biosensor could provide real-time biometric data to the physician as he guided and treated an area of interest. Because all the processing of the signal was performed at the catheter tip, instead of the operating room end of the catheter, as many systems employed, Josh’s SMART Catheter was able to provide a level of imaging resolution far greater than any mapping catheter available today.

With the technology now ready to begin the move to market, Neuro-Kinesis was formed in 2015 where a new management team and dedicated research group continue to develop the technologies to fine-tune everything for final regulatory approval and ultimately move the technologies into licensing agreements for commercialization.